Genesis Drug Discovery and Development (GD3), a member of Genesis Global Group, is a contract research organization focused on providing services to support preclinical drug development programs from discovery to candidate selection. Our diversified portfolio of services covers all the areas of preclinical drug discovery/development including Discovery Biology, Chemistry, DMPK/in-vivo pharmacology and Toxicology. The portfolio spans a wide range of therapeutic areas include oncology, ocular, inflammation, metabolic diseases, and microbiome.
Company Details
- Employees
- 9
- Founded
- -
- Address
- 2439 Kuser Rd, Hamilton,new Jersey 08690,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- gd3services.com
- HQ
- Hamilton, New Jersey
Genesis Drug Discovery & Development (Gd³) Questions
Genesis Drug Discovery & Development (Gd³)'s website is gd3services.com
Genesis Drug Discovery & Development (Gd³)'s LinkedIn profile is https://www.linkedin.com/company/gd3services
Genesis Drug Discovery & Development (Gd³) has
9 employees.
View email and phone details for 9
employees at Genesis Drug Discovery & Development (Gd³).
Genesis Drug Discovery & Development (Gd³)'s industry is
Biotechnology Research
Genesis Drug Discovery & Development (Gd³)'s top competitors are
Montclair Breast Center,
Pharmoptima™,
Syntekabio Inc.,
Medical Diagnostic Laboratories (Mdl),
Ingenio Diagnostics,
Genesis Biotechnology Group,
Genesis Global Group,
Invivotek,
Jss Medical Research,
Venenum Biodesign, Llc.
Genesis Drug Discovery & Development (Gd³)'s categories are Biotechnology Research
Genesis Drug Discovery & Development (Gd³)'s founding year is 2017
